⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Semafor Unveils 450 Top Global CEOs and Government Leaders for Semafor World Economy 2026
prnewswire.com
HON
LLY
LAZ
QCOM
GS
BAH
BKR
PNC
ALL
MET
EXPE
JLL
MSFT
GOOG
NVDA
META
CRWD
VZ
BEN
CAVA
IBM
AMZN
INTC
AMD
CSCO
PANW
ETSY
UBER
LYFT
GE
USFD
SBUX
MCD
YUM
CVS
MRNA
PFE
JNJ
ABBV
BMY
GILD
REGN
AMGN
BIIB
VRTX
AZN
NVO
LULU
URBN
RL
MAT
UAA
INFY
ARM
ISRG
TDOC
TAP
FSLR
NEE
BE
PLUG
FCEL
RUN
SEDG
ENPH
ALNY
CRSP
EDIT
NTLA
ACLS
EXAS
ASO
ATHM
COIN
PYPL
MPWR
ON
AMAT
LRCX
KLAC
ASML
ADI
NXPI
TXN
WIT
HPE
OKTA
FTNT
DDOG
SNOW
PLTR
SPCE
RBLX
Global Diabetes Care Devices Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight
prnewswire.com
BDX
NVO
TNDM
ABT
SNY
MDT
DXCM
SENS
JNJ
Novo Nordisk A/S Investigated by the Portnoy Law Firm
globenewswire.com
NVO
BIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
globenewswire.com
JNJ
LLY
NVO
TEVA
GSK
IFNNY
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
accessnewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
accessnewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
accessnewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
prnewswire.com
NVO
Novo Holdings announces 2025 Annual Results
globenewswire.com
NVO
NVS
EVTC